Results of a phase II study using MIP regimen (Mitomycin+ifosfamide+Cisplatin) in unresectable Non Small Cell Lung Cancer
Dutin, J.P., Lacroix, H., Donnadieu, N., Cumin, I., Dabouis, G.Volume:
29
Year:
1993
Language:
english
DOI:
10.1016/0959-8049(93)91540-2
File:
PDF, 170 KB
english, 1993